All In Biotech

Drug Trial Radar · NCT03928470

Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

A Multicenter, Randomized, Double-blind, Active-controlled Phase 4 Study to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg in Patients With Non-erosive Reflux Disease(NERD)

Last checked: Nov 20, 2026Latest source record: Dec 24, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 379 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

379

Actual

Start

Jan 29, 2019

Primary completion

Dec 20, 2019

Study completion Dec 20, 2019

Sponsor

Lead sponsor
Chong Kun Dang PharmaceuticalIndustry
Sponsor type
Industry
First posted
Apr 26, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

Conditions

  • Non-erosive Reflux Disease(NERD)

Interventions

  • EsoDuo Tab. 20/800mgDrug

    Nexium Tab. 20mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete resolution of heartburn(HB), Last 7 days of treatment, 4 weeks.Time frame: 4 weeks after drug administrations.

Locations

38 sites in 1 country. Site status is shown where the registry gives one.

  • Dong-A University Hospital

    Busan, South Korea

  • Kosin University Gospel Hospital

    Busan, South Korea

  • Soonchunhyang University Cheonan Hospital

    Cheonan, South Korea

  • Chungbuk National University Hospital

    Cheongju-si, South Korea

  • Hallym University Chuncheon Seonsim Hospital

    Chuncheon, South Korea

  • Daegu Catholic Hospital

    Daegu, South Korea

  • Keimyung University Dongsan Medical Center

    Daegu, South Korea

  • Yeungnam University Medicar Center

    Daegu, South Korea

  • Chungnam National University Hospital

    Daejeon, South Korea

  • Myongji Hospital

    Goyang, South Korea

  • Chonnam National University Hospital

    Gwangju, South Korea

  • Ajou University Hospital

    Gyeonggi-do, South Korea

  • Hanyang University Guri Hospital

    Gyeonggi-do, South Korea

  • Inje University ilsan Paik Hospital

    Gyeonggi-do, South Korea

  • Soonchunhyang University Bucheon Hospital

    Gyeonggi-do, South Korea

  • Wonkwang University Hospital

    Iksan, South Korea

  • Dongguk University IIsan Hospital

    Ilsan, South Korea

  • Gachon Gil Hospital

    Incheon, South Korea

  • Jeju National University Hospital

    Jeju City, South Korea

  • Chonbuk National University Hospital

    Jeonju, South Korea

  • Inje University Busan Paik Hospital

    Pusan, South Korea

  • Inje University Haeundae Paik Hospital

    Pusan, South Korea

  • Pusan National University Hospital

    Pusan, South Korea

  • Yangsan Pusan National University Hospital

    Pusan, South Korea

  • Asan Medical Center, Seoul

    Seoul, South Korea

  • Catholic University Seoul St. Mary's Hospital

    Seoul, South Korea

  • Chung Ang University Hospital

    Seoul, South Korea

  • Gangnam Severance

    Seoul, South Korea

  • Hanyang University Hospital

    Seoul, South Korea

  • Konkuk University Hospital

    Seoul, South Korea

  • Korea University Anam Hospital

    Seoul, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

  • Kyunghee Universtiy Hospital

    Seoul, South Korea

  • Samsung Seoul Hospital

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • Severance Hospital

    Seoul, South Korea

  • Soonchunhyang University Seoul Hospital

    Seoul, South Korea

  • Wonju Severance Christian Hospital

    Wŏnju, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.